Novartis to push ahead with disputed Alcon buyout
Swiss drugmaker Novartis AG is pushing ahead with its contentious buyout of Alcon minority shareholders after completing its acquisition of stock from Nestle to get control of the U.S. eyecare group.
Related posts:
- Latest Diovan News
- Latest Topamax News
- Latest Celebrex News
- Latest Strattera News
- Latest Cymbalta News